This inventor holds 1 USPTO granted patent. Top assignee: The University of Hong Kong. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Innovations in Liver Cancer Diagnostics and Treatment: The Work of Nikki Pui Yue Lee
Introduction: Nikki Pui Yue Lee is a notable inventor based in Hong Kong, CN, recognized for his significant contributions to the field of cancer research. With one patent to his name, he has dedicated his work to advancing the diagnosis and treatment of liver cancer. His innovative approach focuses on the role of Cadherin-17, providing new avenues for both therapeutic and diagnostic interventions.
Latest Patents: Nikki Lee's patent, titled "Cadherin-17 as Diagnostic Marker and Therapeutic Target for Liver Cancer," presents compositions and methods aimed at diagnosing, treating, and preventing cancers characterized by CDH17 overexpression. The patent outlines methods for detecting and quantifying the CDH17 protein or its encoding nucleic acids in biological samples, such as urine. It provides innovative strategies for treating liver cancer by targeting CDH17, including methods for sensitizing cells with aberrant expressions of CDH17 through suppression or knockdown techniques.
Career Highlights: Nikki Pui Yue Lee is associated with The University of Hong Kong, where he actively engages in research focused on cancer biomarkers and therapies. His work at the university highlights his commitment to exploring novel solutions for complex medical challenges, particularly in oncology.
Collaborations: Throughout his career, Lee has collaborated with colleagues such as John Moon Ching Luk and Lingxiao Liu, pooling expertise to advance their shared research goals. These collaborative efforts are critical for driving innovation and enhancing the impact of their discoveries within the medical community.
Conclusion: Nikki Pui Yue Lee's work exemplifies the vital intersection of innovation and healthcare. His patent concerning Cadherin-17 as a diagnostic and therapeutic target sheds light on important developments in liver cancer diagnostics and treatment. As medical research continues to evolve, contributions from inventors like Lee will play a crucial role in enhancing patient outcomes and advancing scientific knowledge.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile